Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 2
1965 3
1970 1
1975 1
1978 1
1980 3
1981 1
1982 8
1983 5
1984 2
1985 3
1986 4
1987 1
1988 6
1990 5
1991 3
1992 6
1993 4
1994 5
1995 6
1996 5
1997 10
1998 10
1999 9
2000 20
2001 14
2002 16
2003 21
2004 16
2005 14
2006 25
2007 12
2008 15
2009 22
2010 31
2011 17
2012 18
2013 22
2014 27
2015 24
2016 25
2017 20
2018 42
2019 32
2020 31
2021 44
2022 26
2023 31

Text availability

Article attribute

Article type

Publication date

Search Results

602 results

Results by year

Filters applied: . Clear all
Page 1
Liver enzyme alteration: a guide for clinicians.
Giannini EG, Testa R, Savarino V. Giannini EG, et al. CMAJ. 2005 Feb 1;172(3):367-79. doi: 10.1503/cmaj.1040752. CMAJ. 2005. PMID: 15684121 Free PMC article. Review.
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept.
Vitale A, Cabibbo G, Iavarone M, Viganò L, Pinato DJ, Ponziani FR, Lai Q, Casadei-Gardini A, Celsa C, Galati G, Gambato M, Crocetti L, Renzulli M, Giannini EG, Farinati F, Trevisani F, Cillo U; HCC Special Interest Group of the Italian Association for the Study of the Liver. Vitale A, et al. Among authors: giannini eg. Lancet Oncol. 2023 Jul;24(7):e312-e322. doi: 10.1016/S1470-2045(23)00186-9. Lancet Oncol. 2023. PMID: 37414020 Review.
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database.
Vitale A, Svegliati-Baroni G, Ortolani A, Cucco M, Dalla Riva GV, Giannini EG, Piscaglia F, Rapaccini G, Di Marco M, Caturelli E, Zoli M, Sacco R, Cabibbo G, Marra F, Mega A, Morisco F, Gasbarrini A, Foschi FG, Missale G, Masotto A, Nardone G, Raimondo G, Azzaroli F, Vidili G, Oliveri F, Pelizzaro F, Ramirez Morales R, Cillo U, Trevisani F, Miele L, Marchesini G, Farinati F; Italian Liver Cancer (ITA.LI.CA) group. Vitale A, et al. Among authors: giannini eg. Gut. 2023 Jan;72(1):141-152. doi: 10.1136/gutjnl-2021-324915. Epub 2021 Dec 21. Gut. 2023. PMID: 34933916
Clopidogrel-Induced Eosinophilic Colitis.
Djahandideh Sheijani S, Calabrese F, Pasta A, Marabotto E, Bodini G, Furnari M, Grillo F, Mastracci L, Savarino EV, Savarino V, Giannini EG. Djahandideh Sheijani S, et al. Among authors: giannini eg. ACG Case Rep J. 2023 Aug 3;10(8):e01118. doi: 10.14309/crj.0000000000001118. eCollection 2023 Aug. ACG Case Rep J. 2023. PMID: 37547482 Free PMC article.
Diabetes medications and risk of HCC.
Plaz Torres MC, Jaffe A, Perry R, Marabotto E, Strazzabosco M, Giannini EG. Plaz Torres MC, et al. Among authors: giannini eg. Hepatology. 2022 Dec;76(6):1880-1897. doi: 10.1002/hep.32439. Epub 2022 Mar 22. Hepatology. 2022. PMID: 35239194 Free PMC article. Review.
Is there an 'ideal' diet for patients with NAFLD?
Pugliese N, Plaz Torres MC, Petta S, Valenti L, Giannini EG, Aghemo A. Pugliese N, et al. Among authors: giannini eg. Eur J Clin Invest. 2022 Mar;52(3):e13659. doi: 10.1111/eci.13659. Epub 2021 Aug 2. Eur J Clin Invest. 2022. PMID: 34309833 Review.
Phagocyte chemoattractant receptors.
Boulay F, Naik N, Giannini E, Tardif M, Brouchon L. Boulay F, et al. Among authors: giannini e. Ann N Y Acad Sci. 1997 Dec 15;832:69-84. doi: 10.1111/j.1749-6632.1997.tb46238.x. Ann N Y Acad Sci. 1997. PMID: 9704038 Review.
Pharmacotherapies in eosinophilic esophagitis: state of the art.
Marabotto E, Giannini EG, Zentilin P, Ziola S, Djahandideh Sheijani A, Savarino E, Savarino V. Marabotto E, et al. Among authors: giannini eg. Minerva Gastroenterol (Torino). 2022 Mar;68(1):69-76. doi: 10.23736/S2724-5985.21.02781-1. Minerva Gastroenterol (Torino). 2022. PMID: 35302339 Review.
Prevention Strategies for Esophageal Cancer-An Expert Review.
Marabotto E, Pellegatta G, Sheijani AD, Ziola S, Zentilin P, De Marzo MG, Giannini EG, Ghisa M, Barberio B, Scarpa M, Angriman I, Fassan M, Savarino V, Savarino E. Marabotto E, et al. Among authors: giannini eg. Cancers (Basel). 2021 May 1;13(9):2183. doi: 10.3390/cancers13092183. Cancers (Basel). 2021. PMID: 34062788 Free PMC article. Review.
Esophageal reflux hypersensitivity: Non-GERD or still GERD?
Savarino V, Marabotto E, Zentilin P, Demarzo MG, Pellegatta G, Frazzoni M, De Bortoli N, Tolone S, Giannini EG, Savarino E. Savarino V, et al. Among authors: giannini eg. Dig Liver Dis. 2020 Dec;52(12):1413-1420. doi: 10.1016/j.dld.2020.10.003. Epub 2020 Oct 21. Dig Liver Dis. 2020. PMID: 33097427 Review.
602 results